Jazzy Franchise23.jpg Online

: Net product sales for Xywav increased by 39% in the second quarter alone, reaching blockbuster status.

2023 was the year of "holding the line" for the sports world and "breaking through" for the pharma world. As we look at the data from Jazz Pharmaceuticals and the NBA standings today, it's clear that the bold moves made in 23 are finally paying off. Jazzy franchise23.jpg

: A major shift occurred toward on-demand services , with customers demanding seamless mobile booking for everything from home repairs to wellness. The Bottom Line : Net product sales for Xywav increased by

: The oncology portfolio was on a tear, with Rylaze sales jumping 43% year-over-year by Q3. 2. The Utah Jazz: The "Quiet" Rebuild Jazzy franchise23.jpg